Zobrazeno 1 - 10
of 14
pro vyhledávání: '"O. V. Romanchuk"'
Autor:
E. V. Borodavina, S. I. Kutukova, A. Yu. Shurinov, E. B. Vasil’eva, A. O. Guz, I. V. Grishkevich, S. D. Karateeva, A. R. Shakhmatova, R. S. Slobodyanskiy, O. V. Romanchuk, M. R. Mukhitova, M. P. Karpovich, S. P. Dmitriev, O. S. Saypeeva, K. A. Tolpeykina, S. S. Tolstov, A. V. Makarova, Ya. A. Tyugina, E. G. Ovchinnikova
Publikováno v:
Опухоли головы и шеи, Vol 14, Iss 2, Pp 98-107 (2024)
Differentiated thyroid cancer is one of the most common malignant diseases of the endocrine system. Usually, it responds well to the standard treatment (surgery + radioiodine therapy), especially at early stages. During both treatment and dynamic obs
Externí odkaz:
https://doaj.org/article/2707608dd266460cbd4fca8974d071d9
Autor:
E. V. Borodavina, A. Yu. Shurinov, S. I. Kutukova, E. N. Nedozorova, A. V. Malanchuk, Yu. V. Semenchenko, S. M. Povarkov, K. V. Narovenkova, A. V. Khodkevich, Yu. V. Komoza, K. A. Kofanova, S. P. Dmitriev, E. B. Vasilyeva, S. A. Shikhamirova, M. N. Gorshenina, L. N. Volodina, O. A. Snezhko, O. A. Stativko, D. V. Xenodokhov, Yu. G. Dzhemageldieva, A. I. Khryapa, D. M. Ulimaeva, E. M. Dagba, M. V. Volkonsky, V. M. Filippova, M. O. Skorina, O. V. Romanchuk, I. I. Andrienko, M. V. Shorin, A. A. Ishchenko, R. A. Dumbrava, M. B. Bolieva, F. V. Tsarakhova, Z. A. Gojieva, S. S. Dzhamirzaeva, P. Z. Aidaeva, M. O. Maximov, I. S. Usoltseva, A. O. Milyukova, O. V. Toporkova, V. D. Sychev, S. A. Rudakov, S. T. Sagdieva, M. A. Klochikhin, V. V. Molokova, R. A. Skotnikov, E. N. Yeremina, Yu. A. Panaseikin, Ya. A. Tyugina, Yu. I. Murzina, S. O. Podvyaznikov
Publikováno v:
Опухоли головы и шеи, Vol 13, Iss 4, Pp 73-82 (2024)
Introduction. The multikinase inhibitors have demonstrated high clinical efficacy in treatment of the radioiodine refractory differentiated thyroid cancer. At the same time, the inclusion criteria in the studies has reflected a minimum set of charact
Externí odkaz:
https://doaj.org/article/d9a4c33879434bc1a8e12f558ea03e1d
Autor:
A. A. Rumyantsev, A. E. Protasova, M. Yu. Sheremet, A. Yu. Goryainova, M. V. Volkonskiy, A. G. Kedrova, S. V. Kuzmicheva, O. N. Aymamedova, Kh. S. Musaeva, S. M. Soroka, O. V. Romanchuk, V. N. Orlova, N. G. Graft, M. R. Ibragimova, Yu. I. Merzlikina, L. V. Stepura, L. B. Tatulova, A. A. Abasova, A. A. Akopyan, E. V. Arsenyeva, Yu. V. Vasilyeva, A. V. Belonogov, L. V. Krivolapova, A. A. Bobryshev, D. Yu. Vovk, I. A. Luev, N. R. Abidova, R. S. Zhikhorev, T. A. Zhelezkova, T. T. Grigoryan, T. A. Makarkina, V. A. Ekimov, A. V. Zhizhina, E. V. Karabina, O. A. Kuchevskaya, V. M. Filippova, T. A. Linchenko, A. A. Lisaeva, A. N. Fedorova, K. S. Maystrenko, E. V. Markizova, E. V. Kogay, E. P. Krasnorutskaya, M. E. Popova, Yu. Yu. Pchelin, R. A. Ryanzhina, D. B. Sidorov, E. B. Shakhnovich, S. M. Alekseev, M. V. Zinkevich, I. O. Belogortsev, V. A. Chubenko, V. M. Moiseenko, N. Kh. Abduloeva, A. A. Lebedinets, L. V. Strakh, L. K. Semenov, M. B. Bolieva, F. Z. Aydaeva
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 4, Pp 104-113 (2024)
Aim. To assess the efficacy and safety of lenvatinib and pembrolizumab for the treatment of mismatch repair-proficient endometrial cancer (EC) in routine clinical practice in Russia.Materials and methods. This multicenter, retrospective, cohort study
Externí odkaz:
https://doaj.org/article/b505b127d35446839d80501e03b80b14
Autor:
E. I. Kovalenko, E. V. Artamonova, L. V. Bolotina, L. A. Zhiliaeva, D. M. Ponomarenko, E. V. Karabina, G. Z. Mukhametshina, A. I. Khasanova, E. Yu. Ratner, A. R. Safarova, A. G. Manikhas, N. O. Popova, I. V. Evstigneeva, L. Yu. Vladimirova, L. V. Kramskaya, T. V. Karandeeva, I. R. Suslova, O. V. Romanchuk, V. E. Shikina, A. Yu. Povyshev, M. A. Osipov, E. M. Cherniakova, A. S. Dergunov, M. V. Volkonskiy, I. S. Chernov, I. E. Shumskaya, M. M. Fael, V. I. Garifullina, I. E. Gudkova
Publikováno v:
Медицинский совет, Vol 0, Iss 20, Pp 36-46 (2021)
Introduction. The standard of 1st line treatment of HER2+ metastatic breast cancer (mBC) is double blockade with trastuzumab and pertuzumab + taxane, 2nd line – Trastuzumab-emtazine. There are no standards for further treatment, as well as the opti
Externí odkaz:
https://doaj.org/article/ddfb182fcf6247f0b4a7bd188e53d850
Autor:
I. A. Pokataev, M. A. Lyadova, M. Yu. Fedyanin, A. A. Tryakin, V. F. Chubenko, F. V. Moiseenko, L. A. Zagorskaya, M. L. Stepanova, A. V. Androsova, D. A. Nosov, N. V. Karpova, O. I. Kit, L. Yu. Vladimirova, I. L. Popova, A. V. Belonogov, D. M. Ponomarenko, D. Yu. Yukalchuk, V. E. Shikina, N. V. Ivanova, A. I. Khasanova, A. D. Kruglov, I. Yu. Stradaeva, A. S. Perepletova, V. M. Filippova, N. L. Buzova, O. V. Khavaneva, Kh. S. Musaeva, A. Yu. Goryainova, O. V. Romanchuk, I. Sh. Tespizhek, S. A. Tyulyandin
Publikováno v:
Медицинский совет, Vol 0, Iss 19, Pp 74-82 (2019)
Introduction. The randomized MPACT study showed that nab-paclitaxel plus gemcitabine results in statistically significantly longer life expectancy. The objective of this retrospective study is to obtain relevant data on the efficacy of this combinati
Externí odkaz:
https://doaj.org/article/edea90a163bc42438bb0f9e0ef411a7b
Publikováno v:
TRENDS IN THE DEVELOPMENT OF PHILOLOGICAL EDUCATION IN THE ERA OF DIGITALIZATION: EUROPEAN AND NATIONAL CONTEXTS ISBN: 9789934263033
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0daee24a69368d7240562dccd5202c9e
https://doi.org/10.30525/978-9934-26-303-3-19
https://doi.org/10.30525/978-9934-26-303-3-19
Autor:
O V Romanchuk, R S Koval
Publikováno v:
South archive (philological sciences). :106-111
Publikováno v:
Science and Education a New Dimension. :36-38
Autor:
O V Romanchuk
Publikováno v:
Pedagogical sciences. :71-77